Trifecta results in Retzius-sparing robotic radical prostatectomy: results of a high-volume center

Alberto Olivero , Paolo Dell’Oglio , Francesca Ambrosini , Silvia Secco , Michele Barbieri , Erika Palagonia , Giancarlo Napoli , Elena Strada , Giovanni Petralia , Dario Di Trapani , Carlo Buratto , Marco Martiriggiano , Antonio Galfano , Aldo Massimo Bocciardi

Mini-invasive Surgery ›› 2022, Vol. 6 ›› Issue (1) : 6

PDF
Mini-invasive Surgery ›› 2022, Vol. 6 ›› Issue (1) :6 DOI: 10.20517/2574-1225.2021.117
Original Article

Trifecta results in Retzius-sparing robotic radical prostatectomy: results of a high-volume center

Author information +
History +
PDF

Abstract

Aim: We aimed to evaluate trifecta outcomes after Retzius-sparing robot-assisted radical prostatectomy (rs-RARP).

Methods: We evaluated 1488 patients who had undergone rs-RARP at our institution from 2011 to 2019. All patients filled out questionaries for functional outcomes before surgery, and only patients with baseline continence and IIEF-5 scores of > 16 were included. Biochemical recurrence (BCR) was defined as two consecutive prostatic specific antigen levels of > 0.2 ng/mL after rs-RARP. Postoperative continence was defined as the use of no pads. Potency was defined as the ability to achieve erections for sexual intercourse, with or without phosphodiesterase-5 (PDE-5) inhibitors. A multivariable logistic regression model was performed to identify predictors of trifecta outcome.

Results: In total, 1240 patients were included in the analysis. During the 24-month follow-up time, 149 patients (11.9%) harbored BCR. Urinary continence was observed in 981 patients (79.5%), while 171 (13.8%) still used a safety pad daily after 24 months. Sexual potency was reported in 643 patients (51.9%), of whom 379 (30.6%) had spontaneous erections and 264 (21.3%) used a PDE-5 inhibitor. Overall, the trifecta outcome was reached by 42.1% of the study’s population. The trifecta outcome was easily reached by younger patients and patients who underwent a full nerve-sparing (NS) prostatectomy. In the multivariable model, age [odds ratio (OR) = 0.89; 95% confidence interval (CI): 0.84-0.90; P < 0.01] and type of NS surgery [partial NS (OR = 3.34; 95%CI: 1.01-11; P = 0.04) full NS (OR = 4.57; 95%CI: 1.86-12; P < 0.01)] resulted as independent predictors.

Conclusion: rs-RARP is associated with optimal trifecta outcome rate. Age and NS technique are independent predictors of trifecta outcomes.

Keywords

Prostate cancer / robot-assisted radical prostatectomy / Retzius sparing / functional outcomes / trifecta outcome

Cite this article

Download citation ▾
Alberto Olivero, Paolo Dell’Oglio, Francesca Ambrosini, Silvia Secco, Michele Barbieri, Erika Palagonia, Giancarlo Napoli, Elena Strada, Giovanni Petralia, Dario Di Trapani, Carlo Buratto, Marco Martiriggiano, Antonio Galfano, Aldo Massimo Bocciardi. Trifecta results in Retzius-sparing robotic radical prostatectomy: results of a high-volume center. Mini-invasive Surgery, 2022, 6(1): 6 DOI:10.20517/2574-1225.2021.117

登录浏览全文

4963

注册一个新账户 忘记密码

References

[1]

Sood A,Menon M.Retzius-sparing robot-assisted radical prostatectomy.BJU Int2019;123:7-8

[2]

Patel VR,Schatloff O.Critical review of ‘pentafecta’ outcomes after robot-assisted laparoscopic prostatectomy in high-volume centres.BJU Int2011;108:1007-17

[3]

Bianchi L,Fossati N.Oncologic outcomes in prostate cancer patients treated with robot-assisted radical prostatectomy: results from a single institution series with more than 10 years follow up.Minerva Urol Nefrol2019;71:38-46

[4]

Inoue S,Hayashi T,Matsubara A.Longitudinal analysis of trifecta outcome in Japanese patients with prostate cancer following robot-assisted laparoscopic radical prostatectomy.World J Urol2020;

[5]

Bianco FJ Jr,Eastham JA.Radical prostatectomy: long-term cancer control and recovery of sexual and urinary function (“trifecta”).Urology2005;66:83-94

[6]

Patel VR,Chauhan S.Continence, potency and oncological outcomes after robotic-assisted radical prostatectomy: early trifecta results of a high-volume surgeon.BJU Int2010;106:696-702

[7]

Novara G,D'Elia C,Cavalleri S.Trifecta outcomes after robot-assisted laparoscopic radical prostatectomy.BJU Int2011;107:100-4

[8]

Borregales LD,Tal O.‘Trifecta’ after radical prostatectomy: is there a standard definition?.BJU Int2013;112:60-7

[9]

Galfano A,Grimaldi S,Strada E.A new anatomic approach for robot-assisted laparoscopic prostatectomy: a feasibility study for completely intrafascial surgery.Eur Urol2010;58:457-61

[10]

Mottet N,Briers E.EAU-EANM-ESTRO-ESUR-SIOG Guidelines on Prostate Cancer—2020 update. Part 1: screening, diagnosis, and local treatment with curative intent.Eur Urol2021;79:243-62

[11]

Dalela D,Prasad MA.A pragmatic randomized controlled trial examining the impact of the Retzius-sparing approach on early urinary continence recovery after robot-assisted radical prostatectomy.Eur Urol2017;72:677-85

[12]

Menon M,Jamil M.Functional recovery, oncologic outcomes and postoperative complications after robot-assisted radical prostatectomy: an evidence-based analysis comparing the Retzius sparing and standard approaches.J Urol2018;199:1210-7

[13]

Checcucci E,Fiori C.Retzius-sparing robot-assisted radical prostatectomy vs the standard approach: a systematic review and analysis of comparative outcomes.BJU Int2020;125:8-16

[14]

Olivero A,Piccinelli M.Retzius-sparing robotic radical prostatectomy for surgeons in the learning curve: a propensity score-matching analysis.Eur Urol Focus2021;7:772-8

[15]

Galfano A,Bocciardi AM.Retzius-sparing robot-assisted laparoscopic radical prostatectomy: an international survey on surgical details and worldwide diffusion.Eur Urol Focus2020;6:1021-3

[16]

Galfano A,Panarello D.Pain and discomfort after Retzius-sparing robot-assisted radical prostatectomy: a comparative study between suprapubic cystostomy and urethral catheter as urinary drainage.Minerva Urol Nefrol2019;71:381-5

[17]

Kowalczyk KJ,O'Neill J.Impact of Retzius-sparing versus standard robotic-assisted radical prostatectomy on penile shortening, Peyronie's disease, and inguinal hernia sequelae.Eur Urol Open Sci2020;22:17-22 PMCID:PMC8317841

[18]

Davis M,Marhamati S,Kowalczyk KJ.Retzius-sparing robot-assisted robotic prostatectomy: past, present, and future.Urol Clin North Am2021;48:11-23

[19]

Rosen RC,Smith MD,Peña BM.Development and evaluation of an abridged, 5-item version of the International Index of Erectile Function (IIEF-5) as a diagnostic tool for erectile dysfunction.Int J Impot Res1999;11:319-26

[20]

Montorsi F,Rosen RC.Pasadena Consensus PanelBest practices in robot-assisted radical prostatectomy: recommendations of the Pasadena Consensus Panel.Eur Urol2012;62:368-81

[21]

Autorino R,Dasgupta P.Precision surgery and genitourinary cancers.Eur J Surg Oncol2017;43:893-908

[22]

Porpiglia F,Manfredi M.Total anatomical reconstruction during robot-assisted radical prostatectomy: implications on early recovery of urinary continence.Eur Urol2016;69:485-95

[23]

Puliatti S,Eissa A.Effect of puboprostatic ligament reconstruction on continence recovery after robot-assisted laparoscopic prostatectomy: our initial experience.Minerva Urol Nefrol2019;71:230-9

[24]

Campobasso D,Amparore D.Total anatomical reconstruction during robot-assisted radical prostatectomy in patients with previous prostate surgery.Minerva Urol Nefrol2019;71:605-11

[25]

Xylinas E,Durand X.Evaluation of combined oncological and functional outcomes after radical prostatectomy: trifecta rate of achieving continence, potency and cancer control--a literature review.Urology2010;76:1194-8

[26]

Eastham JA,Kattan MW.Predicting an optimal outcome after radical prostatectomy: the trifecta nomogram.J Urol2008;179:2207-10; discussion 2210-1 PMCID:PMC4270351

[27]

Shikanov SA,Zagaja GP.Trifecta outcomes after robotic-assisted laparoscopic prostatectomy.Urology2009;74:619-23

[28]

Checcucci E,DE Cillis S.San Luigi Study GroupThe importance of anatomical reconstruction for continence recovery after robot assisted radical prostatectomy: a systematic review and pooled analysis from referral centers.Minerva Urol Nephrol2021;73:165-77

PDF

648

Accesses

0

Citation

Detail

Sections
Recommended

/